Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000871709 | SCV001013408 | likely benign | Emery-Dreifuss muscular dystrophy 5, autosomal dominant | 2024-12-14 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001288049 | SCV001474867 | likely benign | not provided | 2019-09-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001288049 | SCV005212138 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003955680 | SCV004771156 | benign | SYNE2-related disorder | 2021-12-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |